AlphAIalphai — Financial news for AI agents
stocktitan.netAUG 251 min read$CGC

Canopy Growth (NASDAQ: CGC) logs new insider trade filing

Canopy Growth Corp (CGC) filed an SEC Form 4, revealing an insider transaction. On 08/24/2026, 13,344 common shares were disposed of at $1.47 each, with 692,162 shares remaining. The filing was made by Shai Marshall, attorney-in-fact for Christelle Gedeon, an officer of the company.

Original reporting
stocktitan.net
Published Aug 25, 2026, 9:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 1:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$CGC
Neutral
high confidence
Mentioned
$CGC
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CGCNeutralLow
01

Why it matters

The disclosed sale is small and unlikely to move the stock, but it adds to the record of insider activity for CGC.

02

Market read

Minor insider sell; limited immediate trading relevance.

03

What to watch

Potential upcoming corporate actions or financing that prompted the sale are not disclosed.

Relevance 4/10Novelty 4/10Timing: filed 08/25/2026

Background

SEC Form 4 filings disclose changes in beneficial ownership by insiders. They are primary sources for insider trading activity.

Company-level read

Ticker impact

$CGCNeutralHigh confidence
Context

Form 4 shows director/officer sold 13,344 shares at $1.47, a small insider disposition.

Expected impact

No significant move expected.

Evidence & confidence

The transaction size is modest relative to float and price, and no broader catalyst is indicated.

Market effects

Sector

None; cannabis sector not materially affected by a single small insider sale.

Regional

None; the filing is US‑based and does not affect regional markets.

Global

None; no global impact.

Counterpoint

What could challenge this read

If the insider has private negative information, the sell could foreshadow downside.

Key entities

  • Company
    Canopy Growth Corp

    Cannabis producer listed on NASDAQ under ticker CGC.

  • Individual
    Christelle Gedeon

    Director/officer of Canopy Growth who filed the Form 4.

Read at source← All news

Related articles

AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min
AUG 21
$CGCMedAI 8/10

Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

Canopy Growth Corporation (CGC) shares rose 15% in a month after reporting Q1 fiscal 2027 earnings that beat estimates, showing revenue growth and improved margins. The company's cannabis business is improving, with increased revenues and narrowing losses. However, cash flow remains a concern, and competition in the cannabis market is stiff. Analysts have slightly improved loss estimates but maintain a 'Hold' rating.

zacks.com3 min
AUG 16
$CURLFMedAI 8/10

Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?

Curaleaf launched an unsolicited offer to buy Aurora Cannabis for $272 million, or $4 per share, about a 45% premium to Aurora’s 30-day VWAP, aiming for about $1.5 billion revenue, $350 million adjusted EBITDA, and $40 million annual cost synergies. The article also discusses whether Canopy Growth could be a future acquisition target, citing its turnaround and global medical cannabis platform.

yahoo.com4 min